146 related articles for article (PubMed ID: 36742361)
1. Prognostic value of estrogen receptors in patients who underwent prostatectomy for non‑metastatic prostate cancer.
Aydın YM; Şahin AB; Dölek R; Vuruşkan BA; Ocakoğlu G; Vuruşkan H; Yavaşcaoğlu İ; Coşkun B
Oncol Lett; 2023 Feb; 25(2):78. PubMed ID: 36742361
[TBL] [Abstract][Full Text] [Related]
2. Association Between Estrogen Receptors and GATA3 in Bladder Cancer: A Systematic Review and Meta-Analysis of Their Clinicopathological Significance.
Bernardo C; Monteiro FL; Direito I; Amado F; Afreixo V; Santos LL; Helguero LA
Front Endocrinol (Lausanne); 2021; 12():684140. PubMed ID: 34690921
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptors α and β and aromatase as independent predictors for prostate cancer outcome.
Grindstad T; Skjefstad K; Andersen S; Ness N; Nordby Y; Al-Saad S; Fismen S; Donnem T; Khanehkenari MR; Busund LT; Bremnes RM; Richardsen E
Sci Rep; 2016 Sep; 6():33114. PubMed ID: 27610593
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of stromal estrogen receptor α and β in prostate cancer.
Daniels G; Gellert LL; Melamed J; Hatcher D; Li Y; Wei J; Wang J; Lee P
Am J Transl Res; 2014; 6(2):140-6. PubMed ID: 24489993
[TBL] [Abstract][Full Text] [Related]
5. Tertiary Gleason pattern in radical prostatectomy specimens is associated with worse outcomes than the next higher Gleason score group in localized prostate cancer.
Özsoy M; D'Andrea D; Moschini M; Foerster B; Abufaraj M; Mathieu R; Briganti A; Karakiewicz PI; Roupret M; Seitz C; Czech AK; Susani M; Shariat SF
Urol Oncol; 2018 Apr; 36(4):158.e1-158.e6. PubMed ID: 29288003
[TBL] [Abstract][Full Text] [Related]
6. Preoperative Predictors of Biochemical Recurrence-Free Survival in High-Risk Prostate Cancer Following Radical Prostatectomy.
Nkengurutse G; Tian F; Jiang S; Wang Q; Wang Y; Sun W
Front Oncol; 2020; 10():1761. PubMed ID: 33014867
[No Abstract] [Full Text] [Related]
7. Biochemical recurrence of pathological T2+ localized prostate cancer after robotic-assisted radical prostatectomy: A 10-year surveillance.
Yang CH; Lin YS; Ou YC; Weng WC; Huang LH; Lu CH; Hsu CY; Tung MC
World J Clin Cases; 2021 Feb; 9(5):1026-1036. PubMed ID: 33644166
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy.
Gandaglia G; Ploussard G; Valerio M; Marra G; Moschini M; Martini A; Roumiguié M; Fossati N; Stabile A; Beauval JB; Malavaud B; Scuderi S; Barletta F; Afferi L; Rakauskas A; Gontero P; Mattei A; Montorsi F; Briganti A
Eur Urol Oncol; 2020 Dec; 3(6):739-747. PubMed ID: 32847747
[TBL] [Abstract][Full Text] [Related]
9. Prediction of biochemical recurrence after radical prostatectomy with PI-RADS version 2 in prostate cancers: initial results.
Park SY; Oh YT; Jung DC; Cho NH; Choi YD; Rha KH; Hong SJ
Eur Radiol; 2016 Aug; 26(8):2502-9. PubMed ID: 26560721
[TBL] [Abstract][Full Text] [Related]
10. Impact of Gleason score on biochemical recurrence in patients with pT3aN0/Nx prostate cancer with positive surgical margins: a multicenter study from the Prostate Cancer Research Committee.
Song W; Lee DH; Jeon HG; Jeong BC; Seo SI; Lee HM; Choi HY; Kim JW; Lee S; Byun SS; Jeong CW; Kwak C; Cho JS; Ahn H; Jeon SS
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2393-2400. PubMed ID: 28823006
[TBL] [Abstract][Full Text] [Related]
11. Expression Patterns of ERα, ERβ, AR, SIRT1, SIRT2, and SIRT3 in Prostate Cancer Tissue and Normal Prostate Tissue.
Choi JH; Choi SM; Lee SW; Jeh SU; Hyun JS; Lee MH; Lee C; Kam SC; Kim DC; Lee JS; Hwa JS
Anticancer Res; 2021 Mar; 41(3):1377-1386. PubMed ID: 33788729
[TBL] [Abstract][Full Text] [Related]
12. Predictive factors and oncological outcomes of persistently elevated prostate-specific antigen in patients following robot-assisted radical prostatectomy.
Kumar A; Samavedi S; Mouraviev V; Bates AS; Coelho RF; Rocco B; Patel VR
J Robot Surg; 2017 Mar; 11(1):37-45. PubMed ID: 27245233
[TBL] [Abstract][Full Text] [Related]
13. Radical prostatectomy neutralizes obesity-driven risk of prostate cancer progression.
Schiffmann J; Salomon G; Tilki D; Budäus L; Karakiewicz PI; Leyh-Bannurah SR; Pompe RS; Haese A; Heinzer H; Huland H; Graefen M; Tennstedt P
Urol Oncol; 2017 May; 35(5):243-249. PubMed ID: 28161322
[TBL] [Abstract][Full Text] [Related]
14. Long-term cancer control outcomes in patients with clinically high-risk prostate cancer treated with robot-assisted radical prostatectomy: results from a multi-institutional study of 1100 patients.
Abdollah F; Sood A; Sammon JD; Hsu L; Beyer B; Moschini M; Gandaglia G; Rogers CG; Haese A; Montorsi F; Graefen M; Briganti A; Menon M
Eur Urol; 2015 Sep; 68(3):497-505. PubMed ID: 26119559
[TBL] [Abstract][Full Text] [Related]
15. The Values of Systemic Immune-Inflammation Index and Neutrophil-Lymphocyte Ratio in Predicting Biochemical Recurrence in Patients With Localized Prostate Cancer After Radical Prostatectomy.
Wang S; Yang X; Yu Z; Du P; Sheng X; Cao Y; Yan X; Ma J; Yang Y
Front Oncol; 2022; 12():907625. PubMed ID: 35719913
[TBL] [Abstract][Full Text] [Related]
16. Quantitative RT-PCR analysis of estrogen receptor gene expression in laser microdissected prostate cancer tissue.
Walton TJ; Li G; McCulloch TA; Seth R; Powe DG; Bishop MC; Rees RC
Prostate; 2009 Jun; 69(8):810-9. PubMed ID: 19189301
[TBL] [Abstract][Full Text] [Related]
17. SERUM ANTIBODIES AGAINST GroEL AS AN ADDITIONAL RISK BIOMARKER OF BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY.
Grygorenko V; Afanasiev Y; Danylets R; Vikarchuk M; Shulyak O
Exp Oncol; 2022 Aug; 44(2):163-168. PubMed ID: 35964651
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
[TBL] [Abstract][Full Text] [Related]
19. Do Second Primary Cancers Affect the Risk of Biochemical Recurrence in Prostate Cancer Patients Undergoing Radical Prostatectomy? A Propensity Score-Matched Analysis.
Kang M; Jung JW; Oh JJ; Lee S; Hong SK; Lee SE; Byun SS
Clin Genitourin Cancer; 2016 Aug; 14(4):e363-9. PubMed ID: 27105723
[TBL] [Abstract][Full Text] [Related]
20. Prognostic classifier for predicting biochemical recurrence in localized prostate cancer patients after radical prostatectomy.
Carrion A; Ingelmo-Torres M; Lozano JJ; Montalbo R; D'Anna M; Mercader C; Velez E; Ribal MJ; Alcaraz A; Mengual L
Urol Oncol; 2021 Aug; 39(8):493.e17-493.e25. PubMed ID: 33189527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
